Mayflower Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-7,009
Closed -$368K – 364
2022
Q4
$368K Sell
7,009
-2,854
-29% -$145K 0.05% 238
2022
Q3
$465K Sell
9,863
-1,009
-9% -$52.4K 0.07% 198
2022
Q2
$548K Sell
10,872
-681
-6% -$37.1K 0.08% 179
2022
Q1
$704K Buy
11,553
+731
+7% +$43.6K 0.09% 155
2021
Q4
$713K Sell
10,822
-3,183
-23% -$204K 0.09% 153
2021
Q3
$891K Buy
14,005
+5,833
+71% +$372K 0.12% 120
2021
Q2
$492K Sell
8,172
-540
-6% -$31.2K 0.07% 173
2021
Q1
$480K Buy
+8,712
New +$483K 0.07% 165

Other funds holding IHI

Mayflower Financial Advisors's IHI Position: Q1 2023 in Review

Mayflower Financial Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2023, closing a stake of 7,009 shares — an estimated $368K sold.

Mayflower Financial Advisors first reported a position in IHI in Q1 2021 and held it in 8 quarters. The position peaked at $891K in Q3 2021. 557 funds tracked by Wall St. Rank hold IHI as of Q1 2023.

  • Mayflower Financial Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2023 after selling out during the quarter.
  • Mayflower Financial Advisors sold 7,009 iShares US Medical Devices ETF shares in Q1 2023, an estimated $368K.
  • Mayflower Financial Advisors first reported a position in iShares US Medical Devices ETF in Q1 2021 and held it in 8 quarters.
  • Mayflower Financial Advisors's iShares US Medical Devices ETF position peaked at $891K in Q3 2021.
  • 557 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2023.

Based on Mayflower Financial Advisors's 13F filing for Q1 2023, filed 12 Apr 2023.